Takeda Chemical Industries Ltd. said Wednesday its group net profit logged a year-on-year rise of 2.2 percent in the first half, hitting 133.67 billion yen.
This marks the fourth straight year in which the firm has posted record-high interim earnings.
The nation's largest drug maker attributed the improvement to brisk sales of mainstay prescription drugs both at home and overseas.